In vivo evaluation of 3D printed polycaprolactone composite scaffold and recombinant human bone morphogenetic protein‐2 for vertical bone augmentation with simultaneous implant placement on rabbit calvaria
- 7 December 2021
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 110 (5), 1103-1112
- https://doi.org/10.1002/jbm.b.34984
Abstract
This study evaluated 3D printed polycaprolactone (PCL) composite scaffold and recombinant human bone morphogenetic protein-2 (rhBMP-2), loaded either onto a PCL composite scaffold or implant surface, for vertical bone augmentation with implant placement. Three-dimensional printed PCL frames were filled with powdered PCL, hydroxyapatite, and β-tricalcium phosphate. RhBMP-2 was loaded to the PCL composite scaffolds and implant surfaces, and rhBMP-2 release was quantified for 21 days. Experimental implants were placed bilaterally on 20 rabbit calvaria, and the PCL composite scaffolds were vertically augmented. The randomly allocated experimental groups were divided by carrier and rhBMP-2 dosage as no rhBMP-2 (control), 5 μg rhBMP-2 loaded to PCL composite (Scaffold/rhBMP-2[5 μg]), 5 μg rhBMP-2 loaded to implant (Implant/rhBMP-2[5 μg]), 30 μg rhBMP-2 loaded to PCL composite (Scaffold/rhBMP-2[30 μg]), and 30 μg rhBMP-2 loaded to implant (Implant/rhBMP-2[30 μg]). Histologic and histometric analyses were conducted after 8 weeks. In both scaffold-loading and implant-loading, rhBMP-2 released initially rapidly, then slowly and constantly. Released rhBMP-2 totaled 23.02 ± 1.03% and 24.69 ± 1.14% in the scaffold-loaded and implant-loaded groups, respectively. There were no significant differences in histologic bone-implant contact (%). Peri-implant bone density (%) was significantly higher in the Scaffold/rhBMP-2(30 μg) and Implant/rhBMP-2(30 μg) groups. Total bone density (%) was not significantly different between the Scaffold/rhBMP-2(5 μg), Implant/rhBMP-2(5 μg), and control groups, or between the Scaffold/rhBMP-2(30 μg) and Implant/rhBMP-2(30 μg) groups, but was significantly higher in the Scaffold/rhBMP-2(30 μg) and Implant/rhBMP-2(30 μg) groups than in the controls. Three-dimensional printed PCL composite scaffold with rhBMP-2 produced vertical osteogenesis and osseointegration, regardless of rhBMP-2 loading to the PCL composite scaffold or implant surface.Keywords
Funding Information
- Ministry of Science and ICT, South Korea (NRF‐2019R1A2C1086515)
This publication has 29 references indexed in Scilit:
- Effects of anodized implants coated with Escherichia coli-derived rhBMP-2 in beagle dogsInternational Journal of Oral & Maxillofacial Surgery, 2012
- Volumetric bone regenerative efficacy of biphasic calcium phosphate‐collagen composite block loaded with rhBMP‐2 in vertical bone augmentation model of a rabbit calvariumJournal of Biomedical Materials Research Part A, 2012
- Improving bioscience research reporting: ARRIVE-ing at a solutionLaboratory Animals, 2010
- Effect of bone block graft with rhBMP-2 on vertical bone augmentationInternational Journal of Oral & Maxillofacial Surgery, 2010
- Evaluation of implants coated with rhBMP‐2 using two different coating strategies: a critical‐size supraalveolar peri‐implant defect study in dogsJournal of Clinical Periodontology, 2010
- Statistical power analyses using G*Power 3.1: Tests for correlation and regression analysesBehavior Research Methods, 2009
- Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein‐2: histologic observationsJournal of Clinical Periodontology, 2008
- The degradation profile of novel, bioresorbable PCL–TCP scaffolds: An in vitro and in vivo studyJournal of Biomedical Materials Research Part A, 2007
- Effects of a novel calcium titanate coating on the osseointegration of blasted endosseous implants in rabbit tibiaeClinical Oral Implants Research, 2007
- Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2Biomaterials, 2005